Jump to main content
Jump to site search

Issue 9, 2017
Previous Article Next Article

MRI-guided tumor chemo-photodynamic therapy with Gd/Pt bifunctionalized porphyrin

Author affiliations

Abstract

Porphyrin derivatives have been widely applied in MR imaging and photodynamic cancer therapy. We here report a novel Gd/Pt bifunctionalized porphyrin derivative (Gd/Pt-P1) for MRI-guided chemo-photodynamic cancer therapy. Gd/Pt-P1 was prepared from tetra(4-pyridyl) porphyrin (P1) via step by step coordination to cisplatin and gadolinium (Gd(III)). Gd/Pt-P1 showed a particularly high synergetic chemo-photodynamic antitumor effect in vivo with a tumor inhibition rate (TIR) of 96.6% and excellent MR imaging performance.

Graphical abstract: MRI-guided tumor chemo-photodynamic therapy with Gd/Pt bifunctionalized porphyrin

Back to tab navigation

Supplementary files

Publication details

The article was received on 15 May 2017, accepted on 12 Jun 2017 and first published on 13 Jun 2017


Article type: Communication
DOI: 10.1039/C7BM00431A
Citation: Biomater. Sci., 2017,5, 1746-1750
  •   Request permissions

    MRI-guided tumor chemo-photodynamic therapy with Gd/Pt bifunctionalized porphyrin

    B. Wu, X. Li, T. Huang, S. Lu, B. Wan, R. Liao, Y. Li, A. Baidya, Q. Long and H. Xu, Biomater. Sci., 2017, 5, 1746
    DOI: 10.1039/C7BM00431A

Search articles by author

Spotlight

Advertisements